The US Food and Drug Administration is proposing limits on the level of nicotine in cigarettes and some other types of tobacco products, such as cigars and pipe tobacco, in order to make them less addictive,

The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious health conditions compared to cigarettes and smokeless tobacco products.

The U.S. Food and Drug Administration issued a rule to drastically reduce the amount of nicotine in cigarettes and other combusted tobacco products.

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.

The U.S. Food and Drug Administration on Thursday okayed the marketing of 20 Zyn nicotine pouch products after undertaking an extensive scientific review of them.

The proposal in the waning days of the Biden administration leaves it up to President-elect Donald Trump to finalize the effort — or scrap it.

A proposed FDA rule would mandate a reduction to minimally addictive or nonaddictive levels, but the incoming Trump administration isn’t expected to follow through on the idea.

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.

New Jersey has considered legislation that would ban the sale of smoke free nicotine pouches, following in the footsteps of some vape products.

Zyn products will be allowed to stay on the market after federal health officials said Thursday that the popular nicotine pouches can help adult smokers cut back or switch completely.

Mass General for Children's Dr. Scott Hadland discusses FDA approval of new nicotine pouch, Zyn.